|
VPS25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.06999999999846E-05 |
| Normal-vs-Stage3 |
1.358450E-03 |
| Normal-vs-Stage4 |
4.505600E-02 |
| Stage1-vs-Stage2 |
2.577800E-01 |
| Stage1-vs-Stage3 |
2.487500E-02 |
| Stage1-vs-Stage4 |
7.134100E-02 |
| Stage2-vs-Stage3 |
4.419200E-01 |
| Stage2-vs-Stage4 |
3.088200E-01 |
| Stage3-vs-Stage4 |
7.790800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.58635343644664E-12 |
| Normal-vs-Asian |
3.940000E-01 |
| Caucasian-vs-AfricanAmerican |
8.435000E-01 |
| Caucasian-vs-Asian |
1.261580E-01 |
| AfricanAmerican-vs-Asian |
1.281240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.92830196255045E-11 |
| Male-vs-Female |
3.521400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.48300000002433E-06 |
| Normal-vs-Extreme_Weight |
2.40918396343659E-14 |
| Normal-vs-Obese |
1.13353770814228E-13 |
| Normal-vs-Extreme_Obese |
1.445860E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.159440E-01 |
| Normal_Weight-vs-Obese |
1.597240E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.984800E-01 |
| Extreme_Weight-vs-Obese |
7.698800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.523400E-01 |
| Obese-vs-Extreme_Obese |
9.557800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.607700E-04 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
5.023900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.454600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.630750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.171700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.551800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.519800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.061600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.51453999999163E-05 |
| Normal-VS-KIRP CIMP |
2.487600E-01 |
| Normal-VS-Unclassified PRCC |
7.0903000004563E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.72313291308046E-12 |
| Type1 PRCC-VS-KIRP CIMP |
4.48440000000438E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.255640E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.623400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.364700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.316400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.75660000048639E-07 |
| Normal-vs-N1 |
5.080700E-03 |
| Normal-vs-N2 |
3.407100E-04 |
| N0-vs-N1 |
1.919570E-02 |
| N0-vs-N2 |
8.159000E-01 |
| N1-vs-N2 |
2.972800E-01 |
|
|
